The efficacy and safety of prednisolone in the prevention of re-accumulation of ascites among endomyocardial fibrosis (EMF) patients at Mulago hospital
Not Applicable
Completed
- Conditions
- Endomyocardial fibrosisCirculatory SystemEndomyocardial (tropical) fibrosis
- Registration Number
- ISRCTN63999319
- Lead Sponsor
- Makerere University College of Health Sciences (Uganda)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
1. Age: 13 years and older, either sex
2. Patients with a diagnosis of endomyocardial fibrosis and ascites
3. For patients already on corticosteroids a wash out period of 1month will be allowed before recruitment into the trial
4. Consent/ assent to participate in the trial
Exclusion Criteria
1. Critically ill patients with unstable vital parameters
2. Use of corticosteroids within the previous month for other indications
3. Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method